Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    403 Forbidden error page is now shown, replacing the expected study record content. The page includes the standard header, navigation, and footer, indicating access is blocked rather than a new or edited study entry.
    Difference
    18%
    Check dated 2026-09-20T03:08:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page shows an updated revision label from v3.6.5 to v3.6.6, indicating a small documentation update.
    Difference
    0.1%
    Check dated 2026-08-29T23:51:27.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision line now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a newly published revision in the site’s version history.
    Difference
    0.1%
    Check dated 2026-08-08T22:31:29.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.3 to v3.6.4. This indicates a maintenance update to the page's template and metadata rather than to its visible content.
    Difference
    0.1%
    Check dated 2026-07-25T13:00:50.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a small release update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:36.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend/template update applied to the study page rather than a change to the clinical trial data.
    Difference
    0.1%
    Check dated 2026-06-26T22:26:49.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.